• Average availability of all survey medicines in the public sector was low/fair/good at X%. When analysis is limited to survey medicines listed on the national EML, public sector availability increases/decreases/stays constant at X%.• In the public sector, originator brands/generics were the predominant/only product type available. OR In the public sector, both originator brands and lowest priced generics were found with similar prevalence. • Average availability in the private sector was low/fair/good at X%. Originator brands/generics were the predominant/only product type available. OR In the private sector, both originator brands and lowest priced generics were found with similar prevalence. • In the private sector, medicine availability was higher than/lower than/similar to that of the public sector. Annex 2 contains the availability of individual medicines in both public and private sectors. In the public sector, medicines with particularly low availability include MEDICINE NAME (X%), MEDICINE NAME (X%), MEDICINE NAME (X%) LIST MEDICINES WITH LOWEST AVAILABILITIES AND INCLUDE THEIR % AVAILABILITIES IN BRACKETS. Note any possible reasons for low availability (e.g. medicine not on EML). In the private sector, medicines with particularly low availability include MEDICINE NAME (X%), MEDICINE NAME (X%), MEDICINE NAME (X%) LIST MEDICINES WITH LOWEST AVAILABILITIES AND INCLUDE THEIR % AVAILABILITIES IN BRACKETS.
Optional Table: Availability of medicines in the public/private sector YOU MAY WISH TO INCLUDE THIS TABLE TO SUMMARIZE THE AVAILABILITY OF INDIVIDUAL MEDICINES IN A GIVEN SECTOR
đang được dịch, vui lòng đợi..